Ads

You May Also Like

Ritter Pharmaceuticals to Present at 30th Annual ROTH Conference on March 13

LOS ANGELES, March 05, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) (“Ritter Pharmaceuticals” ...

RedHill Biopharma Completes Treatment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis

Top-line results are expected in the second quarter of 2017  The randomized, double-blind, placebo-controlled Phase III study ...